Асосий контентга ўтиш
AkademIndex

Маҳсулотлар

Ишлаб чиқувчилар учун

AkademBaseЭкотизим учун очиқ API
← Ишга қайтиш

Ушбу иш иқтибос қилган ишлар

96 та иш

Иш: Advances on Tumor-Targeting Delivery of Cytotoxic Proteins

  1. Intein-mediated site-specific synthesis of tumor-targeting protein delivery system: Turning PEG dilemma into prodrug-like feature

    Yingzhi Chen, Meng Zhang, Hongyue Jin +6

    Мақола20167 иқтибос
    ABI

  2. Prodrug-Like, PEGylated Protein Toxin Trichosanthin for Reversal of Chemoresistance

    Yingzhi Chen, Meng Zhang, Hongyue Jin +4

    Мақола20175 иқтибос
    ABI

  3. Co-Delivery of Trichosanthin and Albendazole by Nano-Self-Assembly for Overcoming Tumor Multidrug-Resistance and Metastasis

    Yisi Tang, Jianming Liang, Aihua Wu +7

    Мақола20174 иқтибос
    ABI

  4. Glioma Dual-Targeting Nanohybrid Protein Toxin Constructed by Intein-Mediated Site-Specific Ligation for Multistage Booster Delivery

    Yingzhi Chen, Meng Zhang, Hongyue Jin +5

    Мақола20174 иқтибос
    ABI

  5. PTD-Modified ATTEMPTS for Enhanced Toxin-based Cancer Therapy: An In Vivo Proof-of-Concept Study

    Meong Cheol Shin, Jian Zhang, Kyoung Ah Min +4

    Мақола20153 иқтибос
    ABI

  6. Heparin-Regulated Prodrug-Type Macromolecular Theranostic Systems for Cancer Therapy

    Huiyuan Wang, Cheol Moon, Meong Cheol Shin +4

    Шарҳ мақола20173 иқтибос
    ABI

  7. The mechanism of action of ricin and related toxic lectins on eukaryotic ribosomes. The site and the characteristics of the modification in 28 S ribosomal RNA caused by the toxins.

    Yaeta Endo, Kazuhiro Mitsui, Mitsuyoshi Motizuki +1

    Мақола19873 иқтибос
    ABI

  8. Cell‐penetrating peptides: Achievements and challenges in application for cancer treatment

    Meong Cheol Shin, Jian Zhang, Kyoung Ah Min +5

    Шарҳ мақола20133 иқтибос
    ABI

  9. Immunotoxins Constructed with Ribosome-Inactivating Proteins and their Enhancers: A Lethal Cocktail with Tumor Specific Efficacy

    Roger Gilabert‐Oriol, Alexander Weng, Benedicta von Mallinckrodt +3

    Шарҳ мақола20143 иқтибос
    ABI

  10. Cell-Targeting Fusion Constructs Containing Recombinant Gelonin

    Mi-Ae Lyu, Yu Cao, Khalid A. Mohamedali +1

    Шарҳ мақола20112 иқтибос
    ABI

  11. The rGel/BLyS Fusion Toxin Inhibits Diffuse Large B-cell Lymphoma Growth In Vitro and In Vivo

    Mi-Ae Lyu, Deepak Rai, Kwang Seok Ahn +7

    Мақола20102 иқтибос
    ABI

  12. Gelonin, a new inhibitor of protein synthesis, nontoxic to intact cells. Isolation, characterization, and preparation of cytotoxic complexes with concanavalin A.

    Fiorenzo Stirpe, Shur Olsnes, Alexander Pihl

    Мақола19802 иқтибос
    ABI

  13. Photochemical internalization: a novel technology for delivery of macromolecules into cytosol.

    Kristian Berg, Pål Kristian Selbo, Lina Prasmickaite +10

    Мақола19992 иқтибос
    ABI

  14. Enhancing the efficacy of cytotoxic agents for cancer therapy using photochemical internalisation

    Alejandra Martinez de Pinillos Bayona, Caroline M. Moore, Marilena Loizidou +2

    Шарҳ мақола20152 иқтибос
    ABI

  15. Recombinant TAT-gelonin fusion toxin: Synthesis and characterization of heparin/protamine-regulated cell transduction

    Meong Cheol Shin, Jingwen Zhao, Jian Zhang +5

    Мақола20142 иқтибос
    ABI

  16. Photochemical activation of MH3-B1/rGel: a HER2-targeted treatment approach for ovarian cancer

    Bente Bull-Hansen, Maria Brandal Berstad, Kristian Berg +6

    Мақола20152 иқтибос
    ABI

  17. The rGel/BLyS fusion toxin inhibits STAT3 signaling via down-regulation of interleukin-6 receptor in diffuse large B-cell lymphoma

    Mi-Ae Lyu, Bokyung Sung, Lawrence H. Cheung +4

    Мақола20102 иқтибос
    ABI

  18. Anti-tumor action of trichosanthin, a type 1 ribosome-inactivating protein, employed in traditional Chinese medicine: a mini review

    Ou Sha, Junfei Niu, Tzi‐Bun Ng +3

    Шарҳ мақола20132 иқтибос
    ABI

  19. Smac is another pathway in the anti-tumour activity of Trichosanthin and reverses Trichosanthin resistance in CaSki cervical cancer cells

    Lei Cui, Jian Song, Liting Wu +7

    Мақола20142 иқтибос
    ABI

  20. Chemically and biologically synthesized CPP-modified gelonin for enhanced anti-tumor activity

    Meong Cheol Shin, Jian Zhang, Allan E. David +5

    Мақола20132 иқтибос
    ABI

  21. Cloning and expression of a gene encoding gelonin, a ribosome-inactivating protein from Gelonium multiflorum

    Patricia A. Nolan, Darryl A. Garrison, Marc Better

    Мақола19932 иқтибос
    ABI

  22. Tumor Cell Killing Enabled by Listeriolysin O-liposome-mediated Delivery of the Protein Toxin Gelonin

    Chester J. Provoda, Ethan M. Stier, Kyung-Dall Lee

    Мақола20032 иқтибос
    ABI

  23. Low-density lipoprotein receptor-related protein 1 is an essential receptor for trichosanthin in 2 choriocarcinoma cell lines

    Yizu Jiao, Wang‐Yi Liu

    Мақола20092 иқтибос
    ABI

  24. Construction and Characterization of Novel, Recombinant Immunotoxins Targeting the <i>Her2/neu</i> Oncogene Product: <i>In vitro</i> and <i>In vivo</i> Studies

    Yu Cao, James D. Marks, John W. Marks +3

    Мақола20092 иқтибос
    ABI

  25. The growth factor fusion construct containing B-lymphocyte stimulator (BLyS) and the toxin rGel induces apoptosis specifically in BAFF-R–positive CLL cells

    Ramadevi Nimmanapalli, Mi-Ae Lyu, Min Du +3

    Мақола20062 иқтибос
    ABI